Visium Asset Management’s GSK GSK Stock Holding History

Visium Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-217,327	Closed	-$11M	–	538
2015 Q4	$11M	Buy	217,327 +100,902	+87%	+$5.14M	0.16%	150
2015 Q3	$5.6M	Sell	116,425 -17,876	-13%	-$931K	0.08%	273
2015 Q2	$6.99M	Buy	134,301 +108,226	+415%	+$6.09M	0.1%	225
2015 Q1	$1.5M	Sell	26,075 -5,925	-19%	-$340K	0.02%	471
2014 Q4	$1.71M	Buy	+32,000	New	+$1.79M	0.02%	441

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Visium Asset Management's GSK Position: Q1 2016 in Review

Visium Asset Management sold out of GSK (GSK) in Q1 2016, closing a stake of 217,327 shares — an estimated $11M sold.

Visium Asset Management first reported a position in GSK in Q4 2014 and held it in 5 quarters. The position peaked at $11M in Q4 2015. 727 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

Visium Asset Management reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
Visium Asset Management sold 217,327 GSK shares in Q1 2016, an estimated $11M.
Visium Asset Management first reported a position in GSK in Q4 2014 and held it in 5 quarters.
Visium Asset Management's GSK position peaked at $11M in Q4 2015.
727 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.